PLEKHA5 expression in melanoma is associated with the early development of brain metastases, and up to 75% of patients with stage IV melanoma develop central nervous system metastases during the course of the disease, according to a study by Jilaveanu et al. (2015). This evidence concerns the gene PLEKHA5 and melanoma.